MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer - Concepedia

Concepedia

Publication | Open Access

MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer

DOI Full Paper Access

56

Citations

32

References

2009

Year

Wenqing Qi, Larry S. Cooke, A Stejskal, Christopher Riley, Kimiko Della Croce, José W. Saldanha, David J. Bearss, Daruka Mahadevan

References

	Year	Citations

Page 1